-
Mashup Score: 2
This is the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0European Commission reaches deal with Vifor for ‘disparaging’ its only rival in iron deficiency market - 3 hour(s) ago
The European Commission has reached a deal with Vifor Pharma after it was accused of disparaging its only rival in the iron deficiency market.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 19
Express Scripts, one of the largest PBMs in the country, overcharged U.S. Postal Service employees by $45 million for their prescription drugs, a federal audit found.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2At a Mass General perfusion lab, a push to make more and more hearts viable for transplant - 15 hour(s) ago
It seems like organized chaos. Five lab members move around a room the size of a galley kitchen. On this day, three high school students also squeeze into
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Up and down the ladder: The latest comings and goings - 19 hour(s) ago
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 4
The insurer UnitedHealth is using its unrivaled physician empire to enrich itself by milking Medicare Advantage.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 11How Kamala Harris' views on health care were shaped by her mother, cancer researcher Shyamala Gopalan - 22 hour(s) ago
Kamala Harris’ late mother, the prominent breast cancer researcher Shyamala Gopalan, helped shape the presidential candidate’s views on health and medicine.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0The worst for Dexcom may not be over - 22 hour(s) ago
Shares of Dexcom plummeted nearly 40% in post-market trading yesterday, after the company lowered its full-year sales guidance. The maker of continuous glucose monitors is now forecasting $4 to $4.05 billion in sales this year.
Source: www.statnews.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 1Pharmalittle: We're reading about a thumbs down for an Alzheimer's drug, Pfizer gene therapy struggles, and more - 23 hour(s) ago
A European Medicines Agency committee that evaluates new drugs recommended that Leqembi, an Alzheimer’s therapy from Eisai and Biogen, should be rejected.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 3Medtech compliance — not regulation — is stifling innovation - 1 day(s) ago
To transform compliance from a red tape burden to a real guardrail, medtech companies should adopt developer-first approaches like shift-left testing.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
In the latest edition of Health Care Inc., UnitedHealth and Elevance Health earnings results portend a rocky second quarter for health insurers. And, don't forget about the young Medicare beneficiaries out there. Read more: https://t.co/oRDs2ptl6R